Skip to main content
In stock|Immunotherapy (Bispecific Antibody)

Tebentafusp

Oncology TypeBoth (Solid & Hematologic)
Drug Class / MechanismBispecific T-Cell Engager
No Image
Description

Tebentafusp is classified as a Bispecific T-Cell Engager, sourced for use within our Immunotherapy (Bispecific Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryImmunotherapy (Bispecific Antibody)
Oncology TypeBoth (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3